Virpax Enters into License Agreement to Develop High-Density Molecular Masking Spray Formulation (MMS019) for the Prevention of Respiratory Viruses

2021-03-26T19:22:01-04:00March 26th, 2021|Press Release|

Virpax Enters into License Agreement to Develop High-Density Molecular Masking Spray Formulation (MMS019) for the Prevention of Respiratory VirusesNasal Powder Spray May Provide Barrier for Cell Transmission of Respiratory Infections [#item_full_content]Virpax Enters into License Agreement to Develop High-Density Molecular Masking [...]

Virpax to Initiate Investigational New Drug (IND) Enabling Studies for Probudur(TM) for Postoperative Pain

2021-03-26T19:21:59-04:00March 26th, 2021|Press Release|

Virpax to Initiate Investigational New Drug (IND) Enabling Studies for Probudur(TM) for Postoperative Pain [#item_full_content]Virpax to Initiate Investigational New Drug (IND) Enabling Studies for Probudur(TM) for Postoperative PainRSS Feed of Press Releases for VRPXRead MoreVirpax to Initiate Investigational New Drug [...]

Go to Top